Primary central nervous system lymphoma other imaging findings

Jump to navigation Jump to search

Primary central nervous system lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Central Nervous System Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary central nervous system lymphoma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary central nervous system lymphoma other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary central nervous system lymphoma other imaging findings

CDC on Primary central nervous system lymphoma other imaging findings

Primary central nervous system lymphoma other imaging findings in the news

Blogs on Primary central nervous system lymphoma other imaging findings

Directions to Hospitals Treating Primary central nervous system lymphoma

Risk calculators and risk factors for Primary central nervous system lymphoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Besides MRI, thallium single-photon emission computed tomography (SPECT) scans have been studied as a diagnostic tool to distinguish between PCNSL and cerebral toxoplasmosis. It was expected that lymphoma cells with a high metabolism would accumulate more thallium than infected,inflamed or normal tissue. Initial thallium SPECT studies showed very high sensitivity and specificity of increased thallium uptake for PCNSL versus cerebral toxoplasmosis in HIV patients. Diagnostic accuracy of 201thallium SPECT is affected by the size, location, malignancy grade, and presence of necrotic and hemorrhagic areas in the lesion.

Other Imaging Findings

  • Besides MRI, thallium single-photon emission computed tomography (SPECT) scans have been studied as a diagnostic tool to distinguish between PCNSL and cerebral toxoplasmosis.
  • It was expected that lymphoma cells with a high metabolism would accumulate more thallium than infected,inflamed or normal tissue.
  • Initial thallium SPECT studies showed very high sensitivity and specificity of increased thallium uptake for PCNSL versus cerebral toxoplasmosis in HIV patients.
  • subsequent studies showed a lower diagnostic accuracy, with a reported mean sensitivity and specificity of 92% and 89% respectively.
  • Diagnostic accuracy of 201thallium SPECT is affected by the size, location, malignancy grade, and presence of necrotic and hemorrhagic areas in the lesion.

References


Template:WikiDoc Sources